HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LY2439821

a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis; in phase I randomized, double-blind, placebo-controlled, proof-of-concept study 4/2010
Networked: 6 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Banerjee, Subhashis: 2 articles (10/2014 - 03/2012)
2. Tang, Cheng-Cai: 1 article (10/2014)
3. Tham, Lai-San: 1 article (10/2014)
4. Satterwhite, Julie H: 1 article (10/2014)
5. Cameron, Gregory S: 1 article (10/2014)
6. Choi, Siak-Leng: 1 article (10/2014)
7. Antoni, Christian: 1 article (04/2013)
8. Kolbinger, Frank: 1 article (04/2013)
9. Lee, David M: 1 article (04/2013)
10. Patel, Dhavalkumar D: 1 article (04/2013)

Related Diseases

1. Psoriasis (Pustulosis Palmaris et Plantaris)
2. Rheumatoid Arthritis
3. Hyperplasia
4. Autoimmune Diseases (Autoimmune Disease)

Related Drugs and Biologics

1. Antirheumatic Agents (DMARD)
2. Interleukins
3. Immunoglobulin G (IgG)
4. Interleukin-17 (Interleukin 27)
5. Peptides
6. LY 165163 (PAPP)